Gilotrif (afatinib) — Medica
Non-small cell lung cancer – Squamous cell carcinoma
Initial criteria
- Patient is age ≥ 18 years
- Patient has metastatic squamous cell carcinoma
- Patient has disease progression after treatment with platinum-based chemotherapy
Approval duration
1 year